COPIED
3 mins

PRECISION FIRST

Emma Wedgwood looks into why the next big thing in 2027 will not be a treatment, but precision.

The most interesting question for 2027 may not be which injectable, device or technique will be the next big thing, but how we use the increasingly sophisticated tools already available to us.

For me, the next stage of aesthetic medicine is about bringing those developments together with better assessment and clinical judgement.

BEYOND THE VOLUME MINDSET

Filler remains an important part of aesthetic medicine, but treatment is moving beyond simply replacing lost volume. Understanding how different products behave in different tissues allows practitioners to select products and techniques according to the individual.

Collagen-stimulating and regenerative treatments are broadening what we can achieve beyond traditional volumisation. A 2026 review in the Journal of Cosmetic Dermatology found the most consistent evidence for sustained tissue remodelling among particulate collagen biostimulators, including poly-L-lactic acid (PLLA), poly-D,L-lactic acid, calcium hydroxyapatite and polycaprolactone. Newer approaches such as polynucleotides, PDRN and extracellular vesicles show promising biological mechanisms, but the clinical evidence for them remains more limited and variable. That distinction matters.

In my view, the future of injectables will be less about choosing between ‘filler’ and ‘regenerative’ treatments and more about understanding what the tissue needs, what each product can realistically achieve and how it fits into the wider treatment plan.

If the last decade of aesthetic medicine was about expanding what we could do, the next will be about becoming more discerning in how we do it

FROM TREATMENTS TO TREATMENT PLANS

The key is knowing where different treatments sit within that plan and what each is being used to achieve. Injectables, collagen biostimulators, energy-based devices and skincare can all influence different aspects of ageing, but combining them effectively requires a clear understanding of anatomy, tissue quality, treatment depth and the expected response.

Rather than following a set protocol, I think we will see more strategic combinations, with the sequence, timing and choice of modalities adapted to the individual patient.

Combining treatments should not mean doing several things simply because they are available. It should mean knowing what each modality contributes, having a clear reason for putting them together and recognising when another treatment adds complexity without improving the outcome.

PREVENTION WITHOUT OVERCORRECTION

The conversation around prevention needs to move beyond the idea that prevention simply means starting injectables earlier.

There is value in recognising changes before they become pronounced, but not every early change needs correcting. Prevention can mean maintaining skin quality, protecting collagen and understanding how someone’s anatomy is likely to change over time, alongside considered decisions about whether treatment is appropriate at all.

I would rather see prevention built around how each individual is likely to age than an expectation that treatment should begin at a particular age.

PRECISION OVER POWER

A similar shift is happening with energy-based treatments. The conversation is becoming less about how powerful a device is and more about how precisely it can target the tissue.

Skin laxity, collagen depletion and changes in skin quality are not the same biological problem, and more sophisticated devices give us further ways of addressing each one. The priority is being clear about what we want to change within the tissue before choosing the technology.

As devices continue to develop, the more useful question is not which is most powerful, but whether its mechanism, depth and treatment parameters suit the patient and the outcome we are aiming for. That moves energy-based treatment away from being technology-led and towards something far more clinically considered.

THE VALUE OF RESTRAINT

If the last decade of aesthetic medicine was about expanding what we could do, the next will be about becoming more discerning in how we do it. We have a deeper knowledge of tissue, more sophisticated injectables, better energy-based technologies and a growing range of treatments designed to influence skin quality and regeneration.

The opportunity now is to bring those advances together in a way that is genuinely individual, using each approach where it adds value rather than treating every concern with the same solution.

That is what makes 2027 so interesting: not the pursuit of the next big treatment, but a more precise, considered and long-term approach to helping patients look like themselves as they age.

EMMA WEDGWOOD

Emma Wedgwood is an advanced nurse practitioner and independent prescriber with over 20 years of medical expertise. Following an extensive career in NHS intensive care, she transitioned to facial rejuvenation in 2018, bringing clinical precision to skin health. Emma holds an MSc in Cosmetic Medicine and serves on the board of BAMAN.

This article appears in Nov/dec 2026

Go to Page View
This article appears in...
Nov/dec 2026
Go to Page View
DEAR READERS
There’s always something new to talk about in
MEET THE EXPERTS
The Aesthetic Medicine editorial board’s clinical expertise and diverse range of specialities help ensure the magazine meets the needs of the readers. In this issue, we have received guidance from the following members:
SKIN QUALITY REDEFINED
As skin quality becomes an increasingly prominent focus in aesthetic practice, Teoxane introduces babyGLOW™ and babyGLOW™ for HIM, two protocols designed to address skin revitalisation with a focus on precision and natural-looking results. 1
HOT OFF THE PRESS
UK government launches consultation on high-risk cosmetic procedures
OUT & ABOUT
REJURAN PRESS TRIP Seoul and Gangneung, South Korea
JEN VITTANUOVA IS… LEGALLY AESTHETIC
Funny, frank and fiercely attached to her patients, Jen Vittanuova is bringing her experience as an aesthetic nurse and expert witness into education. With Legally Blonde as her muse, she is making the case for better consent, sharper records and safer clinics, discovers Kezia Parkins .
CASE STUDY: CHRONIC ACNE AND SCARRING TRANSFORMATION
Treating chronic acne and post-acne concerns with a personalised combination approach
PDRN VS PN: WHAT AESTHETIC PRACTITIONERS NEED TO KNOW
As PDRN moves into topical skincare and injectable polynucleotides gain prominence in clinics, confusion surrounding the two categories is growing. Ellen Cummings examines their proposed mechanisms, evidence and implications for clinical practice.
BEYOND THE SURFACE
A multi-layer approach to skin rejuvenation with RF Microneedling
NEXT UP
Claudia McGloin asks: what should really define the next trend in regenerative injectables?
THE EVOLVING BOOB JOB
Consultant plastic surgeon Paul Banwell on awake surgery, tissue preservation, implant innovation and the future of the “boob job”.
BEYOND THE TEMPLATE
Dr Ahmed El Muntasar argues that safe, individualised aesthetic care requires practitioners to understand anatomical variation, assess skin characteristics and question whose beauty standards shape treatment.
CLINIC TO COSMETIC COUNTER
Dr Farah Latif and Prof Ali Al -Hussaini ask: are professional treatments becoming beauty products?
UNDERSTANDING ICHTHYOSIS VULGARIS
Dr Kemi Fabusiwa and Professor Edel O’Toole explain how to recognise, manage and treat ichthyosis vulgaris, from protecting the skin barrier to supporting patients with long-term care.
RETHINKING THE RESEARCH
Dr Jordan Faulkner on why practitioners need to question the evidence behind the treatments they offer.
PRACTICALLY PERFECT?
As Practical Magic 2 hits cinemas, 28 years after the original, its female stars have ignited a debate around ageing: don’t have too much work done, but don’t show any signs of ageing. Vicky Eldridge asks: how can women in aesthetic medicine help to change the narrative?
PRECISION FIRST
Emma Wedgwood looks into why the next big thing in 2027 will not be a treatment, but precision.
WHEN TRENDS TRAVEL FASTER than governance
From glass skin to treatment stacking, South Korea is shaping patient expectations. But does faster adoption mean better practice? Jen Vittanuova explores what UK aesthetics can learn, and why clinical judgement must keep pace with innovation.
THE UNSEEN WORK OF EXCELLENCE
Why clinical excellence depends on consistent standards, practical experience and knowing when to keep learning.
THE PURSUIT OF EXPERTISE OR THE PURSUIT OF RECOGNITION?
Amy Bird questions whether aesthetic medicine is prioritising visibility and recognition over clinical knowledge.
LEAD WITH THE CONDITION NOT THE CURE
Why condition-led websites win more consultations and keep you on the right side of the ASA.
ASK THE EXPERTS
Which health factors could influence treatment outcomes?
THE INTELLIGENT CLINIC
Dr Askari Townshend looks into why the future of aesthetics will be driven by data.
HOW AI SEARCH IS CHANGING WHERE PATIENTS FIND AESTHETIC CLINICS
AI is changing how patients discover aesthetic clinics. Panita Vig explains what AI search means for clinic visibility and the practical steps practitioners can take now to stay discoverable.
RETHINKING CLINICAL STYLE
Ditching the traditional clinical look, Emma Wedgwood shares how she transformed her treatment room into a space that reflects her style and personality.
PROTECT YOUR PRACTICE
Asking the right questions now can help protect your practice, reputation and clients later,
HYDRAFACIAL NANO-NEEDLING
Connie Cooper visited the Hydrafacial flagship to try their latest treatment: Hydrafacial Deluxe with SkinStylus Nano-Needling.
DOUBLE CHIN TIGHTENING WITH XERF
Contributing reporter Anna Dobbie visits the Seriderm Training Centre to experience XERF, a non-invasive radiofrequency treatment that tightens and firms the skin beneath her chin.
PRODUCT NEWS
AlumierMD AlumierMD has expanded its Biocellulose range with
5 MINUTES WITH ... IAIN DE HAVILLAND
Founder of NADclinic Group, Iain De Havilland discusses evolution of NAD+ therapy and the growing role of personalised longevity medicine in aesthetics.
5 ANATOMY EXPERTS TO FOLLOW
These five specialists are putting facial anatomy, clinical knowledge and education at the forefront of aesthetics.
Looking for back issues?
Browse the Archive >

Previous Article Next Article